Shanghai RAAS Blood Products Co Ltd Class A Tangible Net Worth Ratio
Shanghai RAAS Blood Products Co Ltd Class A tangible net worth ratio. Shanghai RAAS Blood Products Co Ltd Class A (002252) has a Tangible Net Worth Ratio of 97.7% as of June 2026. This metric is calculated by deducting intangible assets (CN¥738.70 Million) from net assets (CN¥32.41 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 002252 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)
Tangible net worth ratio of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2025. This chart shows how Shanghai RAAS Blood Products Co Ltd Class A's Tangible Net Worth Ratio has changed across 21 annual periods from 2005 to 2025. As of June 2026, the ratio stands at 97.7%, reflecting net assets of CN¥32.41 Billion with intangible assets of CN¥738.70 Million CNY. Check Shanghai RAAS Blood Products Co Ltd Clas strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Shanghai RAAS Blood Products Co Ltd Class A Tangible Net Worth Ratio by Year (2005–2025)
Shanghai RAAS Blood Products Co Ltd Class A tangible net worth ratio by year from 2005 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2025, covering 21 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Shanghai RAAS Blood Products Co Ltd Clas.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.7% | CN¥32.47 Billion | CN¥732.55 Million | CN¥37.80 Billion | ▼ -0.7 pp |
| 2024 | 98.5% | CN¥31.94 Billion | CN¥485.01 Million | CN¥33.63 Billion | ▼ -0.7 pp |
| 2023 | 99.2% | CN¥29.65 Billion | CN¥233.85 Million | CN¥31.93 Billion | ▼ -0.2 pp |
| 2022 | 99.4% | CN¥28.81 Billion | CN¥175.49 Million | CN¥30.46 Billion | ▲ +0.0 pp |
| 2021 | 99.4% | CN¥25.90 Billion | CN¥163.18 Million | CN¥27.24 Billion | ▲ +0.1 pp |
| 2020 | 99.3% | CN¥25.13 Billion | CN¥172.42 Million | CN¥25.49 Billion | ▲ +0.9 pp |
| 2019 | 98.4% | CN¥11.49 Billion | CN¥183.79 Million | CN¥11.85 Billion | ▲ +0.2 pp |
| 2018 | 98.2% | CN¥10.90 Billion | CN¥195.27 Million | CN¥11.40 Billion | ▼ -0.1 pp |
| 2017 | 98.3% | CN¥12.48 Billion | CN¥207.04 Million | CN¥14.46 Billion | ▲ +0.4 pp |
| 2016 | 98.0% | CN¥11.73 Billion | CN¥236.61 Million | CN¥13.23 Billion | ▼ -0.5 pp |
| 2015 | 98.5% | CN¥10.71 Billion | CN¥162.35 Million | CN¥11.56 Billion | ▲ +0.4 pp |
| 2014 | 98.1% | CN¥8.62 Billion | CN¥162.95 Million | CN¥9.38 Billion | ▲ +2.4 pp |
| 2013 | 95.7% | CN¥1.10 Billion | CN¥47.43 Million | CN¥1.58 Billion | ▲ +0.3 pp |
| 2012 | 95.4% | CN¥1.02 Billion | CN¥47.05 Million | CN¥1.21 Billion | ▲ +0.6 pp |
| 2011 | 94.8% | CN¥927.27 Million | CN¥48.08 Million | CN¥1.01 Billion | ▲ +0.3 pp |
| 2010 | 94.5% | CN¥831.21 Million | CN¥45.74 Million | CN¥930.33 Million | ▼ 0.0 pp |
| 2009 | 94.5% | CN¥763.33 Million | CN¥41.99 Million | CN¥825.22 Million | ▼ -4.6 pp |
| 2008 | 99.1% | CN¥754.76 Million | CN¥7.00 Million | CN¥831.19 Million | ▲ +1.5 pp |
| 2007 | 97.6% | CN¥170.01 Million | CN¥4.13 Million | CN¥306.54 Million | ▼ -2.4 pp |
| 2006 | 100.0% | CN¥156.77 Million | CN¥0.00 | CN¥325.16 Million | ▲ +0.0 pp |
| 2005 | 100.0% | CN¥231.70 Million | CN¥0.00 | CN¥333.63 Million | — |